- Centers & Specialties
- Medical Education
- MD, Harvard Medical School
- Residency, UC San Francisco
- Board Certifications
- Diagnostic Radiology
- Boston: Massachusetts General Hospital
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Adult and Pediatric
Michael T. Lu, MD, is a board-certified radiologist specializing in cardiovascular imaging, Assistant Professor at Harvard Medical School, and Director of Research, Division of Cardiovascular Imaging at Massachusetts General Hospital.
Dr. Lu earned his undergraduate and medical degrees from Harvard University. His training included a transitional internship in Surgery and Medicine at Newton-Wellesley Hospital, residency in Diagnostic Radiology at the University of California, San Francisco, fellowship in Thoracic and Cardiac Imaging at MGH, and a NIH T32 fellowship in Cardiac Imaging at MGH.
Dr. Lu's clinical expertise is in cardiovascular imaging, including the acquisition and interpretation of CT, MRI, and ultrasound studies of the heart and blood vessels. He co-chairs the mechanistic CT substudy of REPRIEVE, a NHLBI sponsored multicenter randomized controlled trial of statins to reduce coronary plaque and prevent cardiovascular events in persons with HIV. Dr. Lu is the recipient of the American Roentgen Ray Society Scholarship, which supports his work in clinical trials of cardiovascular CT.
Dr. Hoffmann and colleagues report on the prognostic value of non-obstructive CAD identified on coronary CT angiography in Circulation.
55 Fruit Street
Boston, MA 02114-2696